tiprankstipranks
Trending News
More News >
Corcept Therapeutics (CORT)
NASDAQ:CORT
US Market

Corcept Therapeutics (CORT) Income Statement

Compare
1,291 Followers

Corcept Therapeutics Income Statement

Last quarter (Q4 2025), Corcept Therapeutics's total revenue was $202.13M, an increase of 11.12% from the same quarter last year. In Q4, Corcept Therapeutics's net income was $24.29M. See Corcept Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 761.41M$ 675.04M$ 482.38M$ 401.86M$ 365.98M
Gross Profit
$ 748.43M$ 664.16M$ 475.89M$ 396.47M$ 360.70M
Operating Expenses
$ 703.63M$ 527.21M$ 368.61M$ 283.84M$ 236.22M
Depreciation and Amortization
$ 1.89M$ 1.34M$ 1.04M$ 1.26M$ 3.07M
EBITDA
$ 68.35M$ 138.29M$ 108.32M$ 113.89M$ 127.95M
Operating Income
$ 44.80M$ 136.95M$ 107.28M$ 112.63M$ 124.48M
Other Income/Expenses
$ 21.67M$ 24.54M$ 17.27M$ 3.56M$ 529.00K
Pretax Income
$ 66.46M$ 161.49M$ 124.56M$ 116.19M$ 125.01M
Net Income
$ 99.65M$ 139.73M$ 106.14M$ 101.42M$ 112.51M
Per Share Metrics
Basic EPS
$ 0.95$ 1.35$ 1.02$ 0.95$ 0.97
Diluted EPS
$ 0.82$ 1.23$ 0.94$ 0.87$ 0.89
Weighted Average Shares Outstanding
103.86M 103.23M 103.56M 106.79M 115.65M
Weighted Average Shares Outstanding (Diluted)
119.99M 113.48M 111.74M 115.97M 125.96M
Currency in USD

Corcept Therapeutics Earnings and Revenue History